|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102.40 USD | -0.52% |
|
+0.39% | +53.48% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 10.37B 9.88B 9.19B 8.2B 14.56B 879B 16.02B 114B 42.29B 360B 38.93B 38.09B 1,551B | P/E ratio 2024 * |
23.9x | P/E ratio 2025 * | 21.8x |
|---|---|---|---|---|---|
| Enterprise value | 12.77B 12.16B 11.32B 10.09B 17.93B 1,082B 19.72B 140B 52.08B 444B 47.93B 46.9B 1,909B | EV / Sales 2024 * |
2.39x | EV / Sales 2025 * | 2.17x |
| Free-Float |
85.73% | Yield 2024 * |
0.6% | Yield 2025 * | 0.64% |
More valuation ratios
* Estimated data
More news
Last Transcript: Encompass Health Corporation
More recommendations
More press releases
| 1 day | -0.52% | ||
| 1 week | +1.27% | ||
| Current month | -0.52% | ||
| 1 month | +3.53% | ||
| 3 months | +10.05% | ||
| 6 months | +18.53% | ||
| Current year | +53.48% |
1 week
101.48
104.16
1 month
97.57104.55
Current year
65.99104.55
1 year
64.15104.55
3 years
44.33104.55
5 years
44.33104.55
10 years
30.26104.55
| Director | Title | Age | Since |
|---|---|---|---|
Mark Tarr
CEO | Chief Executive Officer | 62 | 2016-12-28 |
Douglas Coltharp
DFI | Director of Finance/CFO | 62 | 2010-05-05 |
| Chief Tech/Sci/R&D Officer | 64 | 2015-07-13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Tarr
BRD | Director/Board Member | 62 | 2016-12-28 |
Joan Herman
BRD | Director/Board Member | 70 | 2013-01-24 |
Leslye Katz
BRD | Director/Board Member | 69 | 2013-01-24 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.44% | 7 M€ | +13.24% | ||
| 1.39% | 2 M€ | -.--% | ||
| 1.09% | 231 M€ | -.--% | ||
| 1.09% | 1 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.52% | +1.27% | +54.24% | +80.92% | 10.37B | ||
| +0.95% | +3.78% | -12.82% | -40.62% | 18.85B | ||
| -0.83% | +0.14% | +23.29% | +9.59% | 14.39B | ||
| 0.00% | -4.72% | -1.94% | +12.22% | 11.7B | ||
| +3.47% | +1.88% | +26.37% | +26.83% | 11.61B | ||
| -0.72% | -0.83% | +33.80% | +93.97% | 8.32B | ||
| +1.01% | +2.41% | -17.70% | -39.93% | 5.91B | ||
| +2.69% | -1.30% | +76.38% | +136.20% | 5.88B | ||
| -1.10% | -4.66% | -20.07% | +4.65% | 4.84B | ||
| -1.46% | -3.63% | -10.48% | +96.04% | 3.91B | ||
| Average | +0.35% | -0.54% | +15.11% | +37.99% | 9.58B | |
| Weighted average by Cap. | +0.48% | +0.30% | +14.90% | +25.18% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 5.35B 5.1B 4.74B 4.23B 7.51B 453B 8.26B 58.78B 21.82B 186B 20.08B 19.65B 800B | 5.83B 5.55B 5.16B 4.6B 8.18B 494B 9B 64.02B 23.76B 202B 21.87B 21.4B 871B |
| Net income | 440M 419M 390M 348M 618M 37.28B 679M 4.83B 1.79B 15.28B 1.65B 1.62B 65.78B | 485M 462M 430M 384M 682M 41.14B 750M 5.33B 1.98B 16.86B 1.82B 1.78B 72.59B |
| Net Debt | 2.4B 2.29B 2.13B 1.9B 3.37B 203B 3.71B 26.36B 9.78B 83.34B 9.01B 8.81B 359B | 2.28B 2.17B 2.02B 1.8B 3.2B 193B 3.52B 25.03B 9.29B 79.14B 8.55B 8.37B 341B |
More financial data
* Estimated data
Employees
27,481
Calendar
2025-01-01
- Détachement de
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-02 | 102.40 $ | -0.52% | 521,081 |
| 24-11-29 | 102.94 $ | +0.10% | 273,193 |
| 24-11-27 | 102.84 $ | -0.90% | 543,892 |
| 24-11-26 | 103.77 $ | +1.74% | 546,807 |
Delayed Quote Nyse, December 02, 2024 at 04:00 pm EST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
102.94USD
Average target price
115.67USD
Spread / Average Target
+12.36%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EHC Stock